Recent posts

Waters GlycoWorks RapiFluor-MS N-Glycan Kit Improves Reproducibility and Speed of N-Glycan Analysis Through Innovation and Automation

By July 22, 2020

Glycosylation is an important post-translational modification that can impact the safety and efficacy of protein therapeutics and is therefore one of the most analyzed product attributes during development and quality control. In released N-glycan analysis, glycans are cleaved from proteins via enzymatic digestion and are chemically derivatized for relative quantification by liquid chromatography coupled… Read more >

Categories: Automation, Pharmaceutical
Tags: ,

The Impact of Complex Global Supply on the Nitrosamine Crisis

By July 9, 2020

When a crisis occurs, hindsight is a great teacher. Any company developing or manufacturing products that impact human health can learn from the recent nitrosamine impurity contamination of angiotensin II receptor blockers (ARBs) by reviewing… Read more >

Categories: Pharmaceutical
Tags: , , , , ,

Change Up Your Routine (Analysis)

By June 23, 2020

Enhancing performance, mitigating risk, and improving efficiency Today, Waters introduced the Arc HPLC, a modern liquid chromatography system that replicates established test methods while delivering improved performance. HPLC has been a cornerstone of routine analytical… Read more >

Categories: Data Integrity, Pharmaceutical, Technologies
Tags: , , , ,

Reveal Molecular Secrets – and Set Them to Work!

By June 23, 2020

From fundamental research to routine analysis, Waters’ latest innovations in mass spectrometry enable our customers to gain – and apply – insights across the scientific spectrum. Beginning with fundamental research where the focus is on… Read more >

Categories: Pharmaceutical, Technologies
Tags: , ,

Navigating the Uncertainties of the Nitrosamine Impurity Crisis

By March 26, 2020

The nitrosamine impurity crisis continues to be on the mind of every stakeholder involved in the development and manufacturing of affected drug products. In our interactions with key opinion leaders and those in the lab having to develop and validate nitrosamine testing methods, we’ve come across a few common questions that we want to address here

Categories: Pharmaceutical
Tags: ,

Nitrosamine Impurities: The Need to Verify

By December 17, 2019

The recent nitrosamine impurity crisis has brought into question the quality of many APIs (Active Pharmaceutical Ingredients) produced and sourced for a number of popular drugs, resulting in product recalls, lost profits, and regulatory actions.… Read more >

Categories: Pharmaceutical
Tags: ,

Webinar Highlights – Improving Analytical Method Performance Through Quality Risk Management and a Design of Experiments Approach

By November 7, 2019

In our most recent Method Lifecycle Management webinar held Improving Analytical Method Performance Through Quality Risk Management and a Design of Experiments Approach, Joseph A. Turpin, Director of Chromatography Products and Services at S-Matrix Corporation and Tran Pham, Business Development Manager at Waters Corporation, presented an overview of Quality by Design approaches to analytical method development (AQbD), the regulatory views on this approach, examples of design of experiments in AQbD, and case studies demonstrating software assisted AQbD method development.

Categories: Pharmaceutical
Tags: , , , , , , ,

More than a slogan, bioharmonization is a unifying principle that aims to enhance productivity

By July 23, 2019

In January of 2018, Waters kicked off its global Bioharmonization campaign with a blog post and video release, laying out a vision for how the Biopharmaceutical industry can achieve accelerated development and improved quality while… Read more >

Categories: Pharmaceutical
Tags: ,

What do great vacations and peptide bioanalysis have in common?

By May 13, 2019

For starters no one wants a disastrous vacation, the same goes for a bioanalysis assay! What makes for a great vacation? A booking agent who understands you, on time transit, a room with a view… Read more >

Categories: Pharmaceutical

Learning from User Experience

By May 8, 2019

What does “intelligence” mean in the context of biopharma analysis? Given the complex setting, much of the answer comes down to the task a user needs to complete, along with the question of who exactly… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , ,